preclinical research
Advisory support to determine starting dose, conduct IND-enabling studies and development of required evidence
![image (2)-1](https://www.propharmagroup.com/hs-fs/hubfs/image%20(2)-1.png?width=414&height=308&name=image%20(2)-1.png)
Trusted Regulatory and Product Development Expertise
Prior to being used in a human, researchers perform testing in controlled laboratory settings. Results during this phase provide researchers with important information about the potential uses in humans and attempts to reduce risk of harm in people. While it is almost never possible to eliminate risk entirely, risk management evaluation can be performed. ProPharma’s expertise spans across the following Preclinical Research competencies:
- Translational/Preclinical Work
- Lead Optimization
- IND/CTA Enabling Studies
- Program Design & Planning
Preclinical Research Services
ProPharma provides advisory support to determine starting dose, conduct IND-enabling studies and development of required evidence. Our robust team of experts will provide the guidance you and your team needs to ensure good laboratory practices (GLP) and will tailor services based on your specific needs.
![pre-clinical research-min](https://www.propharmagroup.com/hs-fs/hubfs/pre-clinical%20research-min.png?width=320&height=155&name=pre-clinical%20research-min.png)
pre-clinical research
Translational / Preclinical Work
Our translational/ preclinical service offerings help move your from discovery to IND prep and submission with confidence and ease. We provide services that meet global requirements across IND-enabling and NDA-enabling that meet global regulatory requirements for molecules of all sizes.
Our solutions include:
- Manufacture of drug substance (DS)/active pharmaceutical ingredient (API)
- Dosage design
- Analytical and bioanalytical methods development and validation
- Pharmacokinetics
- Toxicology, both safety and genetic toxicology
- Good manufacturing practice (GMP).
We partner with you to ensure a frictionless transition to first-in-human trials.
Lead Optimization
As the last step in the preclinical development process, lead optimization is a crucial step for a drug candidate to move into future clinical development. We help you move through the process rapidly and with expert guidance to ensure the most promising compounds are optimized, improving the success probability for your drug candidates. Move confidently from lead optimization to IND study with our comprehensive suite of services and customizable solutions.
IND/CTA Enabling Studies
An investigational new drug (IND) and clinical trial application (CTA) must be completed in both the USA and Europe to progress a compound to first-in-human clinical trials. Successful completion of IND/CTA enabling studies provides detailed analyses for health authority review and allows for formal application submission(s) with the FDA and/or EMA. Health authority requirements vary by region, so it is critical to understand the specific needs of each before IND/CTA enabling studies are designed and planned. Gaining a full understanding of the requirements of each health authority will enable optimal resource allocation and spend.
ProPharma's proven track record with designing and performing IND/CTA preclinical studies enables your team to achieve speed and efficiency with submissions for first-in-human clinical trials.
Program Design & Planning
A well researched strategic roadmap is essential when beginning a new drug development program. This process will enable efficiency, reduce timelines and costs and can potentially increase the probability of success for the program. ProPharma’s diverse team of experts can assist you and your team across target product profile (TPP), regulatory, non-clinical and clinical, manufacturing, and commercial plans. Ensuring all of these components are considered and incorporated into a seamless strategic document plan is the first step in moving towards achieving your program’s objectives.
News & Insights
![Navigating the Regulatory Maze: Clinical Data for Medical Device Approval](https://www.propharmagroup.com/hubfs/images/featured-images/gloved-hands-working-with-medical-devices-ss-542727343-1200x627.webp)
August 29, 2024
Navigating the Regulatory Maze: Clinical Data for Medical Device Approval
Explore clinical data's role in medical device approval, focusing on regulatory criteria, data suitability, and strategic compliance for market success.
![Building Clinical Quality Assurance: Unlock the Full Potential of Your Clinical Development](https://www.propharmagroup.com/hubfs/images/featured-images/medical-professionals-wearing-labcoats-reviewing-fluid-in-test-tube-ss-661174147-1200x627.webp)
August 26, 2024
Building Clinical Quality Assurance: Unlock the Full Potential of Your Clinical Development
Optimize clinical development with Clinical Quality Assurance. Ensure compliance, data integrity, and patient safety to unlock full potential.
![ProPharma Receives 2024 CRO Leadership Award](https://www.propharmagroup.com/hubfs/blogs/press-releases/propharma-clinical-leader-cro-leadership-award.webp)
June 13, 2024
ProPharma Receives 2024 CRO Leadership Award
ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.
![Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device](https://www.propharmagroup.com/hubfs/CF%20Box%20Web%20featured%20image%20-%20%201%20Desktop%20%282%29.jpg)
May 2, 2024
Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device
ProPharma and PBL introduce Cell Factory Box for decentralized Cell & Gene Therapies manufacturing, reducing costs and improving patient access to life-saving treatments.
![ProPharma Receives 2024 CRO Leadership Award](https://www.propharmagroup.com/hubfs/blogs/press-releases/propharma-clinical-leader-cro-leadership-award.webp)
June 13, 2024
ProPharma Receives 2024 CRO Leadership Award
ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.
![EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist](https://www.propharmagroup.com/hubfs/michael-stomberg-EY-national-finalist-blog.png)
November 27, 2023
EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist
Ernst & Young announces Michael Stomberg as a finalized for Entrepreneur Of The Year® 2023 National Award to celebrate ambitious entrepreneurs.
![The Cost of Poor Project Management - ProPharma](https://www.propharmagroup.com/hubfs/Resources/Resources%20Thumbnails/Case%20Studies/the-cost-of-poor-project-management-case-study-thumbnail.webp)
June 10, 2022
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...
![Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma](https://www.propharmagroup.com/hubfs/Resources/Resources%20Thumbnails/Case%20Studies/case-study-gdp-compliance-thumbnail.webp)
August 31, 2022
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...
News & Insights
Complex Needs Require Custom Solutions
ProPharma builds solutions at the intersection of innovation and flexibility. We’re here to offer a custom alternative that fits your unique needs. Standout solutions scaled to your size.